Cargando…
Trimodal therapy in T2‐4aN0M0 bladder cancer––How to select the best candidate?
The reported results of trimodal treatment (TMT) in muscle‐invasive bladder cancer vary widely. We attempted to characterize the profile of ideal candidates for this approach. Between 2000 and 2019, 105 patients (median age 78 years) with T2‐4aN0M0 bladder cancer were treated with TMT and analyzed r...
Autores principales: | Gofrit, Ofer N., Meirovitz, Amichay, Frank, Stephen, Rabinovich, Igal, Luwisch, Hemda, Yutkin, Vladimir, Neuman, Tzahi, Hidas, Guy, Duvdevani, Mordechai, Wygoda, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666756/ https://www.ncbi.nlm.nih.gov/pubmed/32960495 http://dx.doi.org/10.1002/cam4.3478 |
Ejemplares similares
-
Transurethral Prostatectomy Before or After External Beam Radiotherapy: Complications and Reoperation Rates
por: Molineros, Gabriel, et al.
Publicado: (2021) -
The growth rate of “clinically significant” renal cancer
por: Gofrit, Ofer N., et al.
Publicado: (2015) -
High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
por: Mekayten, Matan, et al.
Publicado: (2018) -
Is emergency percutaneous antegrade drainage of the upper urinary tract useful for future percutaneous nephrolithotomy access?
por: Sabler, Itay M., et al.
Publicado: (2019) -
Predicting urine culture results in candidates for lithotripsy
por: Gofrit, Ofer N., et al.
Publicado: (2023)